THE LATEST World Health Organization (WHO) HIV guidelines mark a significant update in global HIV care, reflecting advances in antiretroviral therapy, vertical transmission prevention, and tuberculosis (TB) management. With nearly 40 million people living with HIV worldwide and more than 30 million on treatment by the end of 2024, the guidance aims to accelerate progress towards ending AIDS as a public health threat by 2030.
WHO HIV Guidelines Refine First- and Second-Line ART
Central to the updated WHO HIV guidelines is the continued recommendation of dolutegravir (DTG)-containing regimens as the preferred option for first-line treatment and for individuals failing non-nucleoside reverse transcriptase inhibitor (NNRTI)-based therapy. For patients who experience failure on DTG-containing regimens, protease…